Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Edwards Lifesciences buys BMEYE for $42 mil. Sapien valve sales in Q3 fall below firm’s expectations. Hospira draws FDA warning letter. More news briefs.

You may also be interested in...



FDA Clears Edwards’ Non-Invasive Hemodynamic Monitor For High-Risk Surgical Patients

ClearSight is intended to reduce the risk of post-surgical complications by non-invasively monitoring blood volume and flow based on information gathered by a small finger cuff with an infrared sensor.

FDA Hits Baxter With Two Warning Letters In Four Weeks

The warning letters cite quality system regulation violations related to the firm’s infusion pumps, including inadequate corrective and preventive actions related to complaints of over-infusion and device bladder ruptures.

Reimbursement Briefs: OIG Looks At DME; AHRQ Seeks Imaging Info; MolDx News

OIG announces investigation of Medicare’s competitive bidding program in four states and, separately, finds inappropriate and questionable CMS billing for diabetes test strips. AHRQ seeks information about imaging tests for diagnosis and staging of pancreatic cancer. More reimbursement news.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT031653

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel